Alpha Profiles · Company Profile
Rapport Therapeutics, Inc.
Canonical company identity and public leadership record.
https://registry.alpha.ac/companies/rapport-therapeutics-inc
- Entity
- Public listing published
- Primary listing
- NASDAQ: RAPP
- Verification
- Partially verified
- Last reviewed
- 2026-10-17T04:46:07.749004+00:00
Overview
Alpha's canonical identity and public leadership record for Rapport Therapeutics, Inc..
Canonical AEGIS identity graph
Executive leadership
Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.
Executive team
6 public recordsChief Executive Officer and Director
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 94%
- Evidence
- RAPP DEF 14A executive officersApr 23, 2026
Chief Operating Officer
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 94%
- Evidence
- RAPP DEF 14A executive officersApr 23, 2026
Chief Scientific Officer
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 94%
- Evidence
- RAPP DEF 14A executive officersApr 23, 2026
Chief Medical Officer
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 94%
- Evidence
- RAPP DEF 14A executive officersApr 23, 2026
Chief Development Officer
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 94%
- Evidence
- RAPP DEF 14A executive officersApr 23, 2026
Chief Financial Officer
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 94%
- Evidence
- RAPP DEF 14A executive officersApr 23, 2026
Governance leadership
Boards & Committees
Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.
Record as of Oct 17, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.
Board roles
8 public records- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2023
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2022
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Apr 23, 2026
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
- State
- confirmed
- Effective
- From Jan 1, 2024
- Confidence
- 88%
- Evidence
- DEF 14A d35380ddef14a.htmApr 23, 2026
Committees
4 public recordsMembership and chair roles are projected from current board seats. A chair is shown only when a stored chair flag says so.
AUDIT COMMITTEE
- Chair
- Not stated
- Members
- James I. Healy; John Maraganore
compensation committee
- Chair
- James I. Healy
- Members
- James I. Healy (Chair); John Maraganore; Raymond Sanchez; Robert J. Perez
nominating and corporate governance committee
- Chair
- Robert J. Perez
- Members
- Robert J. Perez (Chair); Steven M. Paul
science and technology committee
- Chair
- Wendy B. Young
- Members
- Wendy B. Young (Chair); Raymond Sanchez; Reid Huber; Steven M. Paul
Source record
Alpha canonical company public projection
Supports Company identity, Published leadership, Entity status boundary
Reviewed 2026-10-17T04:46:07.749004+00:00